PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Pasithea Therapeutics Corp.
Filed: October 31, 2022
Period of Report: October 31, 2022
Accession Number: 0001213900-22-067737

View Document ↗ View on SEC.gov ↗